Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Virus Infection: A Systematic Review Supplementary Table 2
Published: 4 February 2025| Version 1 | DOI: 10.17632/t2bkgtt366.1
Contributor:
Herbert CastilloDescription
Supplemental Table II: Characteristics of included original studies, including first author, publication year, study design, demographics, HSV type, anatomical location, acyclovir-resistance test, prior treatment history, medication dose, frequency, and route, combination treatment, clinical response, remission, follow-up duration, relapse, remission after relapse, and adverse events.
Files
Categories
Infectious Disease